These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23109800)

  • 21. Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.
    Lee YH; Lee EK; Shin KS; Lee KM; Kim JY
    Retina; 2011; 31(7):1287-93. PubMed ID: 21386762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.
    Lim TH; Lai TYY; Takahashi K; Wong TY; Chen LJ; Ruamviboonsuk P; Tan CS; Lee WK; Cheung CMG; Ngah NF; Patalauskaite R; Margaron P; Koh A;
    JAMA Ophthalmol; 2020 Sep; 138(9):935-942. PubMed ID: 32672800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.
    Mori R; Tanaka K; Yuzawa M
    Medicine (Baltimore); 2018 Jun; 97(25):e11188. PubMed ID: 29924037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review.
    Zhao M; Zhou HY; Xu J; Zhang F; Wei WB; Liu NP
    Int J Ophthalmol; 2017; 10(3):413-422. PubMed ID: 28393033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ricci F; Calabrese A; Regine F; Missiroli F; Ciardella AP
    Retina; 2012 Jul; 32(7):1280-8. PubMed ID: 22218148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports.
    Iesato Y; Tanaka M; Murata M; Kitahara J; Hirano T; Kurenuma T; Yoshida N; Murata T
    BMC Ophthalmol; 2018 Nov; 18(1):284. PubMed ID: 30390650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.
    Moon SW; Kim MS; Kim ES; Yu SY; Kwak HW
    Ophthalmologica; 2011; 225(3):169-75. PubMed ID: 21273795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy.
    Sayman Muslubaş I; Hocaoğlu M; Arf S; Özdemir H; Karaçorlu M
    Turk J Ophthalmol; 2016 Jan; 46(1):16-20. PubMed ID: 27800252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Azuma K; Okubo A; Nomura Y; Zhou H; Terao R; Hashimoto Y; Asano KS; Azuma K; Inoue T; Obata R
    Sci Rep; 2020 May; 10(1):8337. PubMed ID: 32433551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy.
    Ngo WK; Chee WK; Tan CS; Lim TH
    BMC Ophthalmol; 2020 Apr; 20(1):150. PubMed ID: 32293353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Matsumiya W; Honda S; Bessho H; Kusuhara S; Tsukahara Y; Negi A
    J Ophthalmol; 2011; 2011():742020. PubMed ID: 21772985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year results of photodynamic therapy with or without intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Sakurada Y; Iijima H
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):832-6. PubMed ID: 23962035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy.
    Maruko I; Iida T; Oyamada H; Sugano Y; Ojima A; Sekiryu T
    Am J Ophthalmol; 2013 Sep; 156(3):548-556. PubMed ID: 23810474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Saito M; Iida T; Kano M
    Retina; 2012 Jul; 32(7):1272-9. PubMed ID: 22547209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Li J; Sun J; Li B; Liu Z
    Exp Ther Med; 2018 Feb; 15(2):1546-1551. PubMed ID: 29434739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results.
    Oishi A; Kojima H; Mandai M; Honda S; Matsuoka T; Oh H; Kita M; Nagai T; Fujihara M; Bessho N; Uenishi M; Kurimoto Y; Negi A
    Am J Ophthalmol; 2013 Oct; 156(4):644-51. PubMed ID: 23876867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2013 Jul; 156(1):95-105.e1. PubMed ID: 23628354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis.
    Tang K; Si JK; Guo DD; Cui Y; Du YX; Pan XM; Bi HS
    Int J Ophthalmol; 2015; 8(5):1056-66. PubMed ID: 26558226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.